PHENOTYPIC VARIABILITY IN SIBLINGS WITH FARBER DISEASE

被引：34

作者：

ANTONARAKIS, SE

VALLE, D

MOSER, HW

MOSER, A

QUALMAN, SJ

ZINKHAM, WH

机构：

[1] JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA

[2] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA

[3] JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA

[4] HOWARD HUGHES MED INST, GENET LAB, BALTIMORE, MD USA

[5] JOHN F KENNEDY INST, BALTIMORE, MD 21205 USA

来源：

关键词：

D O I：

10.1016/S0022-3476(84)81106-3

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：406 / 409

页数：4

共 14 条

[1] DIAGNOSIS OF LIPOGRANULOMATOSIS (FARBER DISEASE) BY USE OF CULTURED FIBROBLASTS
DULANEY, JT
MILUNSKY, A
SIDBURY, JB
HOBOLTH, N
MOSER, HW
[J]. JOURNAL OF PEDIATRICS, 1976, 89 (01) : 59 - 61
[2] DULANEY JT, 1977, PRACTICAL ENZYMOLOGY, P283
[3] FARBER S, 1957, J Mt Sinai Hosp N Y, V24, P816
[4] IWAMORI M, 1975, CLIN CHEM, V21, P725
[5] FARBERS LIPOGRANULOMATOSIS - REPORT OF A CASE AND DEMONSTRATION OF AN EXCESS OF FREE CERAMIDE AND GANGLIOSIDE
MOSER, HW
PRENSKY, AL
WOLFE, HJ
ROSMAN, NP
CARR, S
FERREIRA, G
[J]. AMERICAN JOURNAL OF MEDICINE, 1969, 47 (06) : 869 - &
[6] MOSER HW, 1983, METABOLIC BASIS INHE, P820
[7] QUALMAN SJ, UNPUB FARBERS DISEAS
[8] RISDALL RJ, 1979, CANCER, V44, P993, DOI 10.1002/1097-0142(197909)44:3<993::AID-CNCR2820440329>3.0.CO
[9] 2-5
[10] CERAMIDASE DEFICIENCY IN FARBERS DISEASE (LIPOGRANULOMATOSIS)
SUGITA, M
MOSER, HW
DULANEY, JT
[J]. SCIENCE, 1972, 178 (4065) : 1100 - &